Catherine Wood's XBI Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 0 shares of State Street SPDR S&P Biotech ETF (XBI) worth $0, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in XBI, representing a fresh investment thesis on this company. Largest reduction occurred in Q3 2026, reducing 94 shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's State Street SPDR S&P Biotech ETF (XBI) Holding Value Over Time
Track share changes against reported price movement
Quarterly State Street SPDR S&P Biotech ETF (XBI) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -94 | Sold Out | 0 | $0.00 |
| Q2 2026 | +94 | New Buy | 94 | $157.68 |
Catherine Wood's State Street SPDR S&P Biotech ETF Investment FAQs
Catherine Wood first purchased State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, acquiring 94 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held State Street SPDR S&P Biotech ETF (XBI) for 2 quarters since Q2 2026.
Catherine Wood's largest addition to State Street SPDR S&P Biotech ETF (XBI) was in Q2 2026, adding 94 shares worth $14,822.
According to the latest 13F filing for Q3 2026, Catherine Wood's firm, Ark Investment Management LLC, owns 0 shares of State Street SPDR S&P Biotech ETF (XBI), valued at approximately $0.
As of the Q3 2026 filing, State Street SPDR S&P Biotech ETF (XBI) represents approximately 0.00% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in State Street SPDR S&P Biotech ETF (XBI) was 94 shares, as reported at the end of Q2 2026.